Xavi Richer Vis

Journalist

Author Profile

Xavi Richer Vis is a Toronto-based associate editor for the Canadian Healthcare Network.

Prior to joining CHN, Xavi was a digital editor at Canadian Business magazine and a reporter at the Investigative Journalism Foundation. His bylines can be found in The Globe and Mail, Wired, Maclean’s, TVO Today and The Narwhal, among many others.

Outside work, Xavi loves traveling, reading, horror movies, mezze platters and spending way too much time on Wikipedia.

ARTICLES BY THIS AUTHOR

10/14/2026
U of T researcher Mina Tadrous gets $2.2M to help Canada get ahead of drug shortages
The funding will support the creation of the Canadian Drug Supply Observatory, a national hub that will study medication supply risks.

Xavi Richer Vis
10/6/2026
Why create this barrier? Alberta pharmacists will now need to collect PHNs before handing out naloxone kits
The province says the change will improve its data on naloxone access, but RxA warns the new requirement could discourage some people from getting a potentially life-saving kit.

Xavi Richer Vis
10/1/2026
OCP updates: Expanded-scope learning approach, no tech fee relief, controlled substance policy changes
The college will keep its current fee structure for now, with a broader review of fees planned after financial forecasts are developed.

Xavi Richer Vis
8/18/2026
Ontario pharmacy complaints rose nearly 30% last year. OCP says more analysis is needed to draw any conclusions
While the Ontario College of Pharmacists can't speak with certainty as to what drive the increase, one pharmacy lawyer says expanding scope of practice may be creating more opportunities for patient complaints (but not necessarily signalling a decline in care)

Xavi Richer Vis
8/17/2026
Ready to take the cod liver oil challenge?
The Newfoundland & Labrador Pharmacy Museum preserves the tools that shaped pharmacy practice in Newfoundland.

Xavi Richer Vis
7/30/2026
As other provinces expand pharmacy care, advocates say Manitoba is falling behind
Some pharmacists say the province's limited scope of practice is making it harder to recruit new graduates and restricting access to care for patients.

Xavi Richer Vis
6/29/2026
Alberta pharmacists weigh the benefits, trade-offs of its long-awaited new funding deal
The province says the agreement strengthens pharmacy sustainability, but some pharmacists worry the new clinical billing cap could create fresh challenges.

Xavi Richer Vis
6/22/2026
Alberta pharmacists: Is the new funding increase enough?
We want to hear whether Alberta's new agreement will make a meaningful difference to your practice.

Xavi Richer Vis
6/18/2026
Ontario College of Pharmacists launches consultation on pharmacy standards changes
Proposed amendments aim to support upcoming scope expansions and clarify operational requirements.

Xavi Richer Vis
6/16/2026
Generic drug pricing deal extended through 2028
The two-year extension preserves existing generic drug pricing measures and is intended to help maintain predictable prices for public drug plans across Canada.

Xavi Richer Vis
6/16/2026
B.C. adds two generic GLP-1s to PharmaCare coverage
The new semaglutide products are priced at roughly one-third the cost of brand-name Ozempic and will be covered for eligible patients with Type 2 diabetes.

Xavi Richer Vis
6/15/2026
OCP debates how much leeway pharmacists should have when filling pet prescriptions
Directors approved consultation on a draft animal pharmacy policy, but sparred over whether pharmacists should be allowed to substitute medications when treating animal patients.

Xavi Richer Vis